BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 3164254)

  • 1. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
    Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
    Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
    Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
    Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation.
    Kirsch IR; Bertness V; Silver J; Hollis GF
    J Cell Biochem; 1986; 32(1):11-21. PubMed ID: 3464612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
    Liebermann DA; Hoffman-Liebermann B
    Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of c-ras and c-myc oncogenes in murine erythroleukemias induced by Friend viruses.
    Robert-Lezenes J; Moreau-Gachelin F; Wendling F; Tambourin P; Tavitian A
    Leuk Res; 1984; 8(6):975-84. PubMed ID: 6595484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of protooncogenes related to transformation and cancer progression in rat myoblasts.
    Leibovitch SA; Leibovitch MP; Guillier M; Hillion J; Harel J
    Cancer Res; 1986 Aug; 46(8):4097-103. PubMed ID: 2425941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
    Chen ZX
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of oncogenes in normal and transformed murine B lymphocytes.
    DeCino P; Lernhardt W; Herbst H; Raschke WC
    Oncogene Res; 1988; 3(1):33-7. PubMed ID: 3264606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proto-oncogene expression in mouse leukemia induced by the Mazurenko virus].
    Mazurenko NN; Seniuta NB; Gladkova TI; Mazurenko NP
    Biull Eksp Biol Med; 1988 Jan; 105(1):71-4. PubMed ID: 2827809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
    Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
    J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
    Prochownik EV; Kukowska J
    Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
    Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
    Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
    Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
    Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth properties, differentiation capacity and oncogene expression in metastatic and nonmetastatic Friend leukemia cell variants.
    Sala A; Benedetto A; Elia G; Pulciani S; Ciotta C; Parlanti E; Santodonato L; Belardelli F
    Invasion Metastasis; 1991; 11(4):192-203. PubMed ID: 1765432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
    Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D
    J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
    Kiefer PE; Bepler G; Kubasch M; Havemann K
    Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
    Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
    J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer.
    Yao M; Shuin T; Misaki H; Kubota Y
    Cancer Res; 1988 Dec; 48(23):6753-7. PubMed ID: 2460228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
    Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
    Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression.
    Howard JC; Li Q; Chu W; Zochodne B; Kapoor M; Ung Y; Rosen K; Ben-David Y
    Oncogene; 2001 Apr; 20(18):2291-300. PubMed ID: 11402324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.